Sebastian Szmit Shares Patients’ Perspectives on Decision‑Making for Antithrombotic Therapy in Advanced Cancer
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared an insightful post on LinkedIn:
”Patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer!
The next paper published by our SERENITY Consortium:
Elin Baddeley, Carme Font, Isabelle Mahé, Simon Mooijaart, Anette Arbjerg Højen, Simon Noble, Erik Klok.
International Cardio-Oncology Society
The Multinational Association of Supportive Care in Cancer (MASCC)”
Read the full article here.
Article: “Who am I to say that I’m not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer
Authors: Elin Baddeleya, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate J. Liffordd,Victoria Mailen Arfuch, Nuri Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed, Kathy Seddona, Mark Pearson, Simone P. Mooijaart, Sebastian Szmit, F.A. Klok, Simon Noble, Anette Arbjerg Højen
Stay updated with Hemostasis Today.
-
Aug 4, 2025, 06:00Genotype–Phenotype Understanding in Hemophilia B: Commentary on Factor IX Missense Variants
-
Aug 4, 2025, 05:47National Health Center Week – Recognizing the Vital Role of HTCs in Specialized Care
-
Aug 4, 2025, 05:33Women with Hemophilia Finally Heard: “DISMISSED” Premieres August 22
-
Aug 4, 2025, 04:58Women with Inherited Bleeding Disorders: Overcoming Diagnostic and Clinical Challenge
-
Aug 4, 2025, 01:37EAHAD Launches Italian Booklet to Support Young Girls With Bleeding Disorders During Their First Period
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Aug 4, 2025, 01:09Manuel Monreal Congratulates Authors Ahead of JTH Publication: VTE-Predict Score Validated in RIETE Cohort
-
Aug 3, 2025, 17:48Nathan Connell: What Is The "Mild Equivalent" For Hemophilia A That Is Achieved While on Emicizumab?
-
Aug 3, 2025, 03:54Cedric Hermans on the Inspiring Impact of the WFH Humanitarian Aid Program Worldwide
-
Aug 2, 2025, 20:14Sebastian Szmit Shares Patients’ Perspectives on Decision‑Making for Antithrombotic Therapy in Advanced Cancer
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab